Almansob, Mohammed Ahmed Saad

Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: a randomized controlled trial. [electronic resource] - Arteriosclerosis, thrombosis, and vascular biology Sep 2012 - 2304-13 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1524-4636

10.1161/ATVBAHA.112.252098 doi


Adult
Analysis of Variance
Biomarkers--blood
Blood Urea Nitrogen
C-Reactive Protein--metabolism
Cardiac Surgical Procedures--adverse effects
Cardiotonic Agents--therapeutic use
Caveolin 1--metabolism
China
Creatine Kinase--blood
Creatinine--blood
Female
HSP90 Heat-Shock Proteins--metabolism
Heart Injuries--blood
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage
Interleukin-6--blood
Interleukin-8--blood
Male
Middle Aged
Myocardium--metabolism
Nitric Oxide--metabolism
Nitric Oxide Synthase Type III--metabolism
Phosphorylation
Proto-Oncogene Proteins c-akt--metabolism
Simvastatin--administration & dosage
Single-Blind Method
Stroke Volume--drug effects
Time Factors
Treatment Outcome
Troponin T--blood
Ultrasonography
Ventricular Function, Left--drug effects
p38 Mitogen-Activated Protein Kinases--metabolism